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ABSTRACT
Background
Over 75% of the annual estimated 9.5 million deaths in India occur in the home, and the
large majority of these do not have a certified cause. India and other developing countries
urgently need reliable quantification of the causes of death. They also need better
epidemiological evidence about the relevance of physical (such as blood pressure and
obesity), behavioral (such as smoking, alcohol, HIV-1 risk taking, and immunization history), and
biological (such as blood lipids and gene polymorphisms) measurements to the development
of disease in individuals or disease rates in populations. We report here on the rationale, design,
and implementation of the world’s largest prospective study of the causes and correlates of
mortality.
Methods and Findings
We will monitor nearly 14 million people in 2.4 million nationally representative Indian
households (6.3 million people in 1.1 million households in the 1998–2003 sample frame and
7.6 million people in 1.3 million households in the 2004–2014 sample frame) for vital status and,
if dead, the causes of death through a well-validated verbal autopsy (VA) instrument. About
300,000 deaths from 1998–2003 and some 700,000 deaths from 2004–2014 are expected; of
these about 850,000 will be coded by two physicians to provide causes of death by gender,
age, socioeconomic status, and geographical region. Pilot studies will evaluate the addition of
physical and biological measurements, specifically dried blood spots.
Preliminary results from over 35,000 deaths suggest that VA can ascertain the leading causes
of death, reduce the misclassification of causes, and derive the probable underlying cause of
death when it has not been reported. VA yields broad classification of the underlying causes in
about 90% of deaths before age 70. In old age, however, the proportion of classifiable deaths is
lower. By tracking underlying demographic denominators, the study permits quantification of
absolute mortality rates. Household case-control, proportional mortality, and nested case-
control methods permit quantification of risk factors.
Conclusions
This study will reliably document not only the underlying cause of child and adult deaths but
also key risk factors (behavioral, physical, environmental, and eventually, genetic). It offers a
globally replicable model for reliably estimating cause-specific mortality using VA and
strengthens India’s flagship mortality monitoring system. Despite the misclassification that is
still expected, the new cause-of-death data will be substantially better than that available
previously.
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About 46 million of the estimated 60 million deaths per
year worldwide occur in developing countries [1]. However,
there is a dearth of reliable and accurate information on the
causes and distribution of mortality in these countries. India
has about 9.5 million deaths a year, or about one in six of all
deaths worldwide. Over three-quarters of deaths in India
occur in the home; more than half of these do not have a
certiﬁed cause.
To meet these modern challenges of mortality measure-
ment, the world’s largest prospective study of the causes and
correlates of mortality in India is being undertaken by the
Registrar General of India (RGI)’s Sample Registration
System (SRS). The study, called the Prospective Study of 1
Million Deaths in India, is implemented in close collaboration
with the Centre for Global Health Research at the University
of Toronto, leading Indian and overseas academic institu-
tions, and the Indian Council of Medical Research. The study
has several innovations that are relevant to other developing
countries considering the measurement of mortality and to
recent calls for improved health statistics [2–5]. It uses a well-
validated household instrument to ascertain causes of death
and dual recording methods to improve reliability and
consistency. It is national in scale, representative of the
population, and—by recording underlying demographics—
able to quantify absolute mortality rates. Prospective and
retrospective study designs, such as household and propor-
tional mortality and nested case-control methods, permit
quantiﬁcation of correlates of mortality.
In this report, we present the rationale, design, results of
validation studies to date, key statistical issues, and expansion
to biologic measurement for the Million Death Study in India.
We discuss the challenges in implementing modern mortality
measurement and the implications for global health.
Rationale: Why Measure Mortality?
Historically reliable, representative, routine, low-cost, and
long-term mortality measurements are the key to monitoring
trends in health conditions of the population, detecting new
epidemics (such as HIV/AIDS), spurring research into
avoidable causes of death, evaluating the success of control
programs, and improving accountability for expenditures on
disease control [6,7]. Routinely collected data have helped to
spur further research and public health action and con-
tributed to the enormous increases in life expectancy in the
20th century [8].
Public health in industrialized countries was transformed
when vital statistics on age, sex, and socioeconomic distribu-
tion of births and deaths became available in the late 19th
and 20th centuries. Vital statistics have demonstrated major
trends in fertility, child survival, and mortality. They have
shown good news, such as the large declines in under-5
mortality and tuberculosis mortality during the 20th century.
They have also raised alarm; in the mid-1940s, a dramatic
increase in lung cancer deaths in British and American men
after World War II led to much research on smoking [9]. In
the early 1980s, routine mortality data from San Francisco
revealed an exceptional increase in immune-related deaths
among young men and signaled the start of the American
HIV-1 epidemic [10].
Vital statistics need to keep up with modern patterns of
disease. India and other countries have seen consistent
decreases in child mortality (under-5 mortality has fallen by
about 2% per year since 1971 in India [11]). Adult deaths in
middle age (35–69 y) attributable partially to the effects of
smoking, sedentary lifestyles, and higher saturated fat intake
have been on the rise. More recently, deaths among young
adults (15–34 y) have risen from HIV/AIDS. Reliable
information on the diseases of adults and their causes are a
large gap in global knowledge.
Recorded deaths from most communicable diseases or
injuries generally correspond to their causes (for example,
malaria deaths are caused by Plasmodium parasites), but the
more ‘‘chronic’’ communicable diseases (such as tuberculosis)
and most noncommunicable diseases can have multiple
causes. For example, a myocardial infarction could be caused
by smoking, elevated blood pressure, high lipids, or other
factors. The age- and sex-speciﬁc importance of established
risk factors, or combinations of risk factors, has only recently
been reliably documented through appropriately large
studies in Western populations, and with surprising results.
For example, the association of blood pressure and vascular
disease is twice as steep as previously believed [12] if blood
pressure is measured reliably and the effects of ‘‘regression-
dilution’’ bias [13] are properly considered. There are few
epidemiological studies that document the age-, sex-, and
region-speciﬁc hazards of blood pressure, blood lipids, and
smoking in developing populations [14], where most of the
world’s vascular deaths occur [1].
Anecdotal evidence suggests that in India each disease that
is common in one part of the country is relatively uncommon
elsewhere, for reasons that are not understood. This means
that there are important avoidable causes that still await
discovery. Much more remains to be discovered about the
novel genomic, proteomic, and other biochemical correlates
of respiratory, intestinal, or other infections in general, and
of the avoidable causes of chronic diseases such as cancer,
heart attack, stroke, and lung disease[15,16] that currently
account for most of the adult mortality in India. Even for
infections such as HIV-1 and tuberculosis, there may well be
genetic causes (such as polymorphisms in genes involved in
innate [17,18] or adaptive [19] immune recognition) or
environmental causes (such as other infections [20,21] other
than the relevant pathogens) that make particular infections,
or progression from infection to disease, more probable.
Alternative Designs for Measuring Mortality
The ideal mortality measurement system has several
characteristics [7]. It is routine, reproducible, long-term,
low-cost, and sustainable. It is reliable and representative of
the population (implying that it avoids major selection biases
in enrollment). It captures not only the death, but also reliably
the cause based on the International Statistical Classiﬁcation of
Diseases and Related Health Problems (ICD-10 [22]). The ideal
system includes not only events or ‘‘numerators,’’ but also
underlying population demographics (‘‘denominators’’).
Three systems measure mortality in India (http://www.
censusindia.net/). The ﬁrst, the Civil Registration System, is
currently unreliable due to gross underregistration. While
some areas have very good vital registration (Mumbai provides
death registration as far back as 1848 [23]), overall, only 3.5
million of the estimated 9.5 million annual deaths were
registered in India in 1999. Among registered deaths, cause-
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this often merely subdivides deaths as due to accident,
violence, or disease, without further details. Civil registration
is the accepted mortality measurement system in Western
countries where coverage nears 100%. However, access to
medical care is far less common in India, and most deaths
occur at home rather than in hospitals. Eventually, civil
registration will increase, as has happened recently in China.
But this may take decades; the United States took the better
part of a century to increase death certiﬁcation, and some
states did not have complete coverage until the 1970s [24].
The second system is the Medically Certiﬁed Causes of
Death. However, this covers only about 0.4 million deaths and
is largely conﬁned to selected urban settings that are not
representative of the general population. Problems with
inconsistent physician attribution of causes of death, espe-
cially for senility and ill-deﬁned causes have been noted [6,7].
The third is the SRS (described in detail below). Only the
SRS is representative of both urban and rural settings of
India, covering some 6,700 to 7,600 units randomly selected
from the preceding census. The SRS is much smaller, though,
covering only 0.05 million deaths. Thus, its chief drawback is
that it cannot yet provide district-level data for local decision
making, and it lacks sufﬁcient power to generate yearly rates
for less common causes, such as maternal deaths. Until
recently, the SRS did not adequately capture information on
causes of death. However, we have addressed this gap by
developing and implementing verbal autopsy (VA)—an
innovative method to estimate cause-speciﬁc mortality.
Finally, it is worth noting that econometric models of cause-
speciﬁc mortality [1] are no replacement for direct measure-
ment. Indirect estimates are only as good as their underlying
data. The econometric models have not been well tested in the
presence of HIV/AIDS growth. In India the global burden of
disease varies considerably depending on the assumptions
used. For example, the 1994 global burden of disease
estimated 0.78 million cancer deaths in 1990, but cancer
registry data suggested a much lower ﬁgure of 0.43 million
deaths [25]. The 1996 version of the global burden of disease
projected 0.95 million deaths from tuberculosis in 2000; the
1999 version estimated 0.42 million deaths in 1998 [26].
Study Objectives
In light of the above, we have the following objectives: (a) to
reliably document cause-speciﬁc mortality from 2001 to 2003
(3 y; approximately 150,000 deaths) within the SRS to
establish regional-, gender-, and age-speciﬁc variation and
patterns of mortality; (b) to document causes of death with
routine use of VA in the new SRS sampling frame from 2004
to 2014 (10 y; approximately 700,000 deaths expected); (c) to
improve our understanding of selected risk factors, most
notably tobacco use, alcohol use, indoor air pollution, fertility
preferences for male children and its effect on female
survival, immunization, and migration through linking of
mortality outcomes with exposure status, using retrospective
and prospective methods; and (d) to expand the new SRS to
obtain reliable epidemiological evidence about the relevance
of physical (such as blood pressure and peak ﬂow), behavioral
(such as migration and HIV-1 risk), and biological (such as
blood lipids and gene polymorphisms) measurements to the
development of disease in individuals or disease rates in
populations.
Methods
Study Setting
This study is conducted within the SRS, a large, routine
demographic survey and the primary system for the collec-
tion of Indian fertility and mortality data since 1971 [27].
There are two SRS sample frames. The ﬁrst SRS sample frame
covers 6.3 million people (including 2.9 million adults aged 25
y or older) in all 28 states and seven union territories of India.
An average of 150 households are drawn from each of 6,671
sample units (4,436 rural and 2,235 urban), which in turn are
selected using 1991 census data. The new SRS sample frame
covers about 7.6 million people (including 3.5 million adults
aged 25 y or older) in all 28 states and seven union territories
of India. Households are drawn from 7,597 sample units
(4,433 rural and 3,164 urban) selected from the 2001 census.
SRS sample units are randomly selected to be representa-
tive of the population at the state level. The sample design is a
unistage stratiﬁed simple random sample without replace-
ment. The sample size for the ﬁrst and new SRS sample
frames are based on total fertility rates and infant mortality
rates, respectively. Within the SRS, selected households are
continuously monitored for vital events by two independent
surveyors. The ﬁrst is a part-time enumerator (commonly a
local school teacher familiar with the area/village) who visits
the home every month. The second is a full-time (nonmedical)
RGI surveyor who visits the home every 6 mo. Each
independently records the births and deaths in the household
for a 6-mo period. A third staff member does a reconciliation
of the two reports, arriving at a ﬁnal list of births and deaths
for each household, which completes each half-yearly survey.
The RGI surveyors each cover about 150 households with a
total average population of 900 (ranging from 700 to 1,500),
and report about 50 deaths (and about 150 births) every 6 mo.
Plan of Investigation
Box 1 and Figure 1 provide an overview of the study
methods. In brief, the method involves 800 trained (non-
medical) RGI surveyors implementing VA reports among
enrolled populations every 6 mo. A random 10% of the VA
ﬁeldwork is repeated by an independent audit team. After
data entry, ﬁeld reports are sent electronically to two
independent and trained physicians who assign cause of
death, based on the ICD-10 [22], using a Web-based system.
The two physicians have to agree on the underlying cause of
death, and if they do not, such records undergo reconciliation
and third-physician adjudication.
Text S1 S3 provide the details of the ﬁeld collection
methods, resampling, physician coding, data management,
and research ethics. The full protocol, ﬁeld instruments,
training manuals, slide presentation of validation results, and
procedures are available at http://www.cghr.org/project.htm.
Estimated Sample Size and Distribution
The primary outcomes of interest are all-cause mortality
and cause-speciﬁc mortality. We expect about 150,000 cause-
speciﬁc deaths determined through VA and about twice as
many deaths (300,000) to study all-cause mortality in the
1998–2003 sample frame. The expected age distribution of
cause-speciﬁc deaths captured with VA, based on the age-
speciﬁc SRS death rates in 2001, is shown in Figure 2. Using
indirect World Health Organization estimates on causes of
death in India [1], we also show the approximate numbers of
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ages 25 to 69 y (Table 1).
As of November 2005, 140,000 VA reports have been
collected from all SRS units, and about 35,000 records have
undergone double physician coding and reconciliation.
Overall we expect several thousand tuberculosis, vascular,
and cancer deaths among adults. Such numbers are not
excessively large, particularly if the age- and sex-speciﬁc
relevance of several risk factors is to be assessed simulta-
neously. For example, assuming a power of 90% and two-
sided a of 0.001, and assuming a 40% smoking rate among
male controls, the study would have sufﬁcient power to detect
relative risks among men as low as 1.4 for lung cancer, 1.1 for
all cancers or for tuberculosis, and 1.1 for cardiovascular
disease [28]. Thus, the study has robust statistical power to
detect small but signiﬁcant increases in risk for most key
variables of interest.
The main planned analyses involve simple tabulations and
standard Cox proportional hazards analyses, calculating
relative risks that are standardized for age, educational level,
and selected covariates as relevant. Analyses of adult deaths
will focus on deaths at ages 25–69 y, as these are much less
likely to be misclassiﬁed than deaths occurring after age 70.
Sample-size estimates for the 2004–2014 sample frame are
less certain, as the cause-speciﬁc child and adult mortality will
depend on the rapidity of declines in childhood mortality and
increases in HIV-1-related mortality [11]. However it is
reasonable to assume that with expanding sample size
(reﬂecting the growth of populations in the SRS households),
some 700,000 deaths will occur over the 10-y period.
Reliable Measurement of Absolute Rates and Relative
Risks
The ability to generate absolute rates depends on complete-
ness of enumeration and being able to calculate underlying
demographic denominators, including migration. Evaluations
suggest that the SRS has a high ascertainment rate of expected
events, although adjustments may be needed for certain age
groups. A 1984 study [29] concluded that the system captured
90% of deaths between 1971 and 1980. The SRS, which
employs continuous enumeration, is more sensitive at detect-
ing child deaths than are single surveys, and it has recorded
more child deaths than those estimated by the National Family
Health Survey 2 (NFHS-2), a nationally representative
demographic and health survey that interviewed nearly 0.1
million households (http://nfhsindia.org/index.html). Bhat [30]
found that adult deaths were underreported by about 13% to
Figure 1. SRS VA Activities
DOI: 10.1371/journal.pmed.0030018.g001
Figure 2. Expected Number of Deaths by Age Group Using VA
(Thousands), 2001 to 2003
DOI: 10.1371/journal.pmed.0030018.g002
Box 1. SRS VA Methods Overview
Design of verbal autopsy questionnaire. Combined open/closed
format. Structured questions accompanied by an open-ended narrative.
Symptom list to assist attribution of deaths.
Questionnaire layout. One-page, double-sided, scannable forms. Four
age-specific forms (neonatal, child, adult, and maternal). Forms available
in either English or Hindi.
Interviewers. Nonmedical RGI surveyors (mostly male) with knowledge
of local language(s) and trained in VA instrument.
Interview technique. One-on-one interviews during home visits.
Duration of 30–45 min.
Respondents. Family members or other informants (usually neighbors
or close associates of the deceased).
Recall period. Usually less than 6 mo, but still valid up to 3 y.
Data quality. Random resample of 10% of all deaths to ensure
completeness of fieldwork.
Derivation of diagnosis. Central medical review of cause by two
independent physicians using modified VA reports (Physician Reports)
and an Internet-based Web application. Adjudication of disagreements
by an expert physician.
Mortality classification. The International Classification System of
Diseases and Related Health Problems, Tenth Revision (ICD-10).
Sample size. One million deaths (about 0.3 million from 1998–2003, 0.7
million from 2004–2014).
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suggest that the undercount has increased slightly in partic-
ular states recently. It is expected that the new SRS sample
frame should have corrected the underreporting of adult
deaths noted in the ﬁrst SRS sample frame. Formal demo-
graphic evaluation will be done once results from the new SRS
are collected. Because household composition is updated
every 6 mo, and in-migration and out-migration are traced, it
should be possible to calculate absolute mortality rates in the
population, including person years at risk. Deaths among in-
migrating groups can be excluded, as the death report lists if
the person was a usual resident in the SRS unit or not. Some
periodic correction for undercount will be needed.
Loss to Follow-Up
The baseline survey for the study was called the Special
Fertility and Mortality Survey (SFMS) and was conﬁned to
usual residents of households only [31]. Those living in these
households in 1998 were a subselection of the SRS baseline
sample frame originally done in 1993. Experience from a
prospective study in Chennai (V. Gajalakshmi, personal
communication) suggests that if people are resident for a
few years, they are not likely to move again. Thus, the
enrolled group in the current SRS sample frame is less likely
to migrate than would be the general population. This is
supported by data from our own small pilot examination of
389 randomly chosen SRS records in two northern states,
which showed that only 6% (25/389) of the households had
moved from 1998 to 2002.
Nonetheless, we do expect loss to follow-up caused by out-
migration from the SRS unit. The risk ratios would be biased
downward if such loss to follow-up is nondifferential between
exposed and unexposed groups. Similarly, risk ratios would
be biased downward if impoverished people (who are most
likely exposed to smoking and other risk factors) migrate.
Results
Validation Studies of Mortality Outcomes
VA relies on the assumption that most causes of death have
distinct symptoms and signs that can be recognized, recalled,
and reported by household members or associates of the
deceased to a trained, usually nonmedical ﬁeld-worker.
Further, it is assumed that deaths characterized through VA
possess a distinct set of features that can be distinguished
from other underlying causes of death [32]. Thus, diseases
with very distinct symptoms and signs, such as tetanus, that
are recognized by the local population may be more suitable
for VA than systemic diseases, such as malaria, which is
associated with many common symptoms and signs. Factors
that inﬂuence the validity and reliability of VA include the
VA instrument (mortality classiﬁcation, diagnostic proce-
dures), the data collection procedures (recall period, inter-
viewer’s characteristics, respondent’s characteristics), and the
underlying distribution of cause-speciﬁc mortality in a given
population [33–35]. Although there is variation in the
sensitivity and speciﬁcity for speciﬁc conditions, VAs are
now of established value in helping to classify the broad
patterns of mortality for childhood deaths in populations
that are not covered by adequate medical services. VAs have
also been used to assess the causes of maternal deaths [36].
Background work for this study included two validation
studies of adult deaths in India [37–39]. The ﬁrst study [37,38]
developed and tested a VA instrument among 48,000 adult
deaths in urban Chennai and 32,000 adult deaths in rural
Tamil Nadu, including a 5% random resample. VA conducted
by trained nonmedical ﬁeld-workers resulted in 90% success-
ful reporting on cause of deaths for middle-age adults (25–69
y). The VA instrument reduced the proportion of adult (age
25 or older) deaths attributed to unspeciﬁed or unknown
causes from 54% to 23% in urban areas and from 41% to 26%
in rural areas. VA yielded fewer unspeciﬁed causes (only 10%)
than the death certiﬁcate (37%)—particularly for the deaths
that did not occur in hospital—and often yielded somewhat
more speciﬁc information, for example, about the approx-
imate site of origin of a cancer, or about evidence of
tuberculosis, stroke, myocardial infarction, or diabetes (Table
2). The urban Tamil Nadu study also compared VA results to
those from a Chennai population-based cancer registry. The
VA sensitivity to identify cancer was 95% in the age group 25–
69 y, and VA identiﬁed 288 deaths that were not registered in
the Chennai Cancer Registry.
The second validation study compared all-cause mortality
determined by VA against hospital-based records for 262
adult deaths in northern India [39]. Deaths characterized with
VA were compared to medically certiﬁed cause-of-death
certiﬁcates for patients who had died in a hospital. Cause-
speciﬁc mortality fractions assigned by the VA method were
statistically similar to the causes arrived at by review of
hospital records (p . 0.05). Speciﬁcity was high (.95%) for all
broad cause groups except cardiovascular (79%) diseases.
Sensitivity was highest for injuries (85%), and it was in the
range of 60% to 65% for circulatory diseases, neoplasms, and
infectious diseases. Sensitivity was low (20% to 40%) for
respiratory, digestive, and endocrine diseases. These ﬁgures
are broadly in agreement with the results from a multicenter
validation study of VA for adult deaths conducted in Africa,
which found a sensitivity and speciﬁcity of 82% and 78%,
Table 1. Expected Number of Deaths between Ages 25 and 69
by Cause (Thousands), 2001 to 2003
Causes Male Female
All infections and maternal diseases 9.2 5.9
Tuberculosis 3.4 1.5
HIV/AIDS 1.9 0.4
Lower respiratory infections 1.3 1.0
Maternal conditions N/A 1.1
Other infections 2.6 1.9
All noncommunicable diseases 21.2 14.6
Lung cancer 0.8 0.2
Upper aerodigestive cancer
(mouth, oropharynx, esophagus)
0.8 0.3
Other cancers 1.8 2.3
Cardiovascular diseases 11.4 7.6
Chronic obstructive pulmonary disease 2.4 1.5
Other noncommunicable 4.0 2.7
Injuries 4.5 2.5
Unintentional 3.2 1.9
Intentional 1.3 0.6
Total (thousands) 34.9 23.0
The expected numbers of deaths for these causes were calculated by using the 2001 estimates of mortality from the
global burden of disease for India ([1]; http://www.fic.nih.gov/dcpp/gbd.html) and multiplying the proportion of
specific causes by the total age-specific number of deaths expected in the SRS study during the follow-up from 2001
to 2003.
N/A, not available.
DOI: 10.1371/journal.pmed.0030018.t001
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and speciﬁcity of 71% and 87%, respectively, for all
noncommunicable diseases [34].
Preliminary results from two states indicate that the
distribution of underlying causes of death based on the
random reinterview does not differ substantially from the
cause of death derived from the VA reports of the original
RGI surveyors (Table 3).
Validation Studies of Exposures Measured at Baseline
Baseline exposures were captured in a one-time SFMS
conducted within the SRS in February 1998. Baseline
exposures captured in the SFMS included socioeconomic
information (education, occupation, household income,
household composition), water and sanitation facilities and
other living conditions, smoking and its type (bidi, cigarette,
hukka, or other), age at onset, alcohol use and frequency per
week, past history of various medical conditions, and the type
of cooking fuel used (major and secondary, and use of a
separate kitchen). The survey also recorded deaths, although
not their causes, in 1997 [31].
The 2004 baseline survey in the new SRS sample frame
(2004–2014) recorded similar exposures and added history of
disability from various medical conditions, recent short-term
illnesses, tobacco smoking and chewing, alcohol use, vegeta-
rianism, and maternal history, including contraceptive use
and pregnancies.
The reliability and representativeness of the SFMS baseline
survey can be assessed, in part, by comparing the age-speciﬁc
prevalence of smoking and alcohol consumption among
males found in the SFMS and other standard surveys, such as
the Indian Census or NFHS-2. Text S1 provides additional
validation studies, such as birth order of children and
measures of indoor air pollution.
Age-Specific Prevalence of Smoking in Adult Males
Smoking is currently common only among Indian males.
The SFMS and NFHS-2 report very similar trends in age-
speciﬁc prevalence of current male smokers. The steepest
increase in prevalence of smoking is between 20–30 y of age
(Figure 3). Similarly, the prevalence of smoking among males
across 25 states shows a strong correlation between the two
Table 2. Cause of Death Based on Vital Statistics and VA of 48,000 Adult (.25 y of Age) Deaths in Chennai, India: 1995–1997
a
Cause of Death Cause of Death in Vital Statistics Division Cause of Death Based on VA
Male (Percent) Female (Percent) Male (Percent) Female (Percent)
Vascular disease 8,319 (30) 5,168 (25) 11,056 (41) 7,435 (37)
Tuberculosis (TB) 1,399 (5) 372 (2) 2,231 (8) 575 (3)
Other respiratory diseases 1,088 (4) 596 (3) 1,597 (6) 855 (4)
Neoplasm 1,163 (4) 1,002 (5) 2,344 (9) 1,999 (10)
Infection (excluding respiratory and TB) 584 (2) 303 (2) 1,034 (4) 618 (3)
Unspecified medical 12,291 (44) 11,511 (56) 4,367 (16) 5,889 (29)
Other specified medical 1,899 (7) 1,045 (5) 4,414 (16) 2,804 (14)
Cause not known 983 (4) 634 (3) Nil Nil
Total deaths: medical 27,726 20,631 27,043 20,175
Total deaths: external causes Excluded 683 456
Total deaths (medical þ external) 27,726 20,631 27,726 20,631
a See [37,38].
DOI: 10.1371/journal.pmed.0030018.t002
Table 3. Cause of Death Results for RGI Surveyors and Resample Teams in Tamil Nadu, Maharashtra, and Goa Using VA (Deaths .28 d)
in 2003
Causes Tamil Nadu Maharashtra/Goa
RGI Surveyors Resample Team RGI Surveyors Resample Team
Number Percent Number Percent Number Percent Number Percent
Vascular 300 25.8 46 28.2 412 23.5 80 25.0
Tuberculosis (respiratory) 50 4.3 1 0.6 85 4.8 8 2.5
Other respiratory diseases 105 9.0 10 6.1 154 8.8 22 6.9
Cancer 100 8.6 18 11.0 113 6.4 15 4.7
Infection 127 10.9 24 14.7 139 7.9 44 13.8
Diabetes 42 3.6 3 1.8 56 3.2 6 1.9
Peptic ulcer 21 1.8 0 0 7 0.4 2 0.6
Undefined/inadequate information 164 14.1 23 14.1 152 8.7 45 14.1
Other specified 95 8.2 12 7.4 480 27.4 74 23.1
External causes 161 13.8 26 16 155 8.8 24 7.5
Total (n) 1,165 — 163 — 1,753 — 320 —
DOI: 10.1371/journal.pmed.0030018.t003
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Million Death Study in Indiastudies (Pearson correlation coefﬁcient or r
2 of 0.92; data not
shown). We plan to remeasure the extent of smoking by each
of several thousand living adults so as to correct for
regression-dilution bias [13]. Additionally, to verify and
validate smoking status, we will use a simple hand-held
carbon monoxide breathalyzer on about 1,000 smokers and
nonsmokers in select states. These simple breathalyzers
appear to be effective at detecting smoking status [40].
Age-Specific Alcohol Consumption in Adult Males
As with smoking, a similar pattern in age-speciﬁc alcohol
consumption is captured by the SFMS and NFHS-2 (Figure 4).
The discrepancy in absolute prevalence for each age group
may be due to the difference in the sex of the respondents,
where females are either overreporting male alcohol con-
sumption in the household in the NFHS-2, or males are
underreporting their own consumption in the SFMS. It
should also be noted that, unlike the NFHS-2, usually the
male head of the household is the respondent of the SFMS.
Retrospective Household Case-Control and Proportional
Mortality Methods
The determinants of death can be identiﬁed by comparing
risk factors between the dead and living. Such household case-
control studies use the dead as cases and their surviving
spouses or close relatives as controls. A retrospective study in
Chennai of 43,000 male deaths and 35,000 living controls [41],
using these methods, has documented that throughout middle
age, the death rates from medical causes of smokers were
double those of nonsmokers (standardized risk ratio at ages
25–69 of 2.1, with 95% conﬁdence interval 2.0–2.2, smoking-
attributable fraction 31%). A large part of this excess risk was
from tuberculosis and vascular deaths. If these hazards are
similar across India, then about half of all tuberculosis deaths
in India could be accounted for by smoking. We will apply
similar retrospective methods for smoking, tobacco chewing,
and alcohol, as these exposures are gathered for dead adults
and from a living household respondent.
Simply asking about the dead person’s risk factors could be
useful. A recent retrospective study of 1 million deaths in
China compared the proportions of smokers and nonsmokers
who have died of tobacco-attributable diseases versus non-
tobacco-related diseases (chieﬂy injuries), to calculate the
excess in smokers [42]. Our preliminary pilot studies among
childhood deaths in Northern India found that 61% of
children (16/26) who died of vaccine-preventable diseases
were not immunized in comparison to 40% of control
children (18/45) who died from injuries. The crude odds ratio
of 2.4 suggests that half of the vaccine-preventable child
deaths need not have occurred.
Using these two retrospective methods, we are conducting
validation studies of selected risk factors such as childhood
immunization, childhood malnutrition, alcohol, male time
away from home (as a proxy of HIV-1-related sexual risk
taking), and other variables.
Discussion
Key Design Challenges
Several challenges stand out in the design and implemen-
tation of this massive study. First is its sheer size. A total of 14
million people is a large sample frame, but commensurate
with the needs of monitoring health status among the one
billion people in India. The study builds upon the routine
infrastructure that has been in place for over 30 y within the
SRS. It works with the leading demographic research
organization in India (for example, the decennial census
involves the RGI hiring two million enumerators to survey
about 150 million households within 25 d). Second is the need
for simpliﬁcation of methods to make such a scale of study
practicable. The study is not the only epidemiological study
needed in India, but its unique focus and scale raise
important challenges in the development of new methods.
The Million Death Study uses a ‘‘large simple’’ design, which
places speciﬁc demands on ensuring that new procedures
(such as the new VA instrument and physical and biological
measurements) are rigorously tested, piloted, and simpliﬁed.
The third challenge is sustainable funding. The current SRS
sample frame is being followed on a total incremental budget
of US$2 million (or less than 33¢ per person). This does not
include the core funding of the RGI surveyors and related
infrastructure. With inclusion of those, the overall study can
still be done in a highly cost-effective manner at well under
US$1 per person. Collection, processing, and long-term
storage of biological samples is expected to cost US$2–5 per
person for dried blood spots and US$10–20 per person for a
10-ml tube of blood. These costs compare extremely
favorably with those existing biobanks in the United King-
dom and elsewhere [43,44]. Most of the infrastructure costs
Figure 3. Prevalence of Current Male Smokers: SFMS 1998 versus NFHS-2
1998–1999
DOI: 10.1371/journal.pmed.0030018.g003
Figure 4. Prevalence of Current Male Alcohol Drinkers: SFMS 1998 versus
NFHS-2 1998–1999
DOI: 10.1371/journal.pmed.0030018.g004
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Million Death Study in Indiawill be sustained by the Government of India. However, we
believe that redirecting some of the considerable, and often
inefﬁcient, spending on monitoring individual disease proj-
ects is required to enhance the SRS.
Key Design Issues for Blood-Based Genetic Epidemiology
Discovery of ‘‘new’’ risk factors should beneﬁt from the
recent and extraordinarily rapid progress by many different
research groups and biotechnology companies in developing
low-cost, miniaturized methods for the simultaneous assay in
small volumes of blood (or, perhaps, dried blood spots) of vast
numbers of nucleic acid fragments, host genetic factors,
proteins, small molecules, and pathogens [45]. This rapid
biotechnological progress has been backed by increasingly
sophisticated computer software to help interpret the mass of
numerical information that can be generated from each
person’s blood, yielding within the next few years many, as yet
unforeseen, qualitatively different analytic capacities. Appro-
priately large-scale epidemiological studies that acquire blood
(or other) samples from individuals and systematically link
them to relevant measures of disability and future mortality
are required to make such technological progress relevant to
human populations. It is particularly important for such
studies to address the shortcomings of the existing biological
sample collections that are now being undertaken [43,44],
including the particular circumstances of India and the
speciﬁc infectious diseases common to developing countries.
Key issues which arise in moving to blood-based epidemi-
ology include the choice of blood sample, long-term storage
and retrieval, and statistical design issues.
Choice of Blood Sample
Biological specimen collection procedures will build on
experience in China, India, and elsewhere. We will undertake
pilot studies to test the feasibility and acceptability of
methods, to ensure that biological samples collected can
serve as a long-term source of DNA for genotyping and that
material collected is suitable for biochemical, hematological,
proteomic, and other assays [46]. Major options include a
nonfasting blood sample collected into one 10-ml ethyl-
enediaminetetraacetic acid Vacutainer, which has been
shown previously by the University of Oxford laboratory to
allow a wide range of assays [47]. This system is used by the
ongoing Chinese Kadoorie Study of 500,000 adults and by the
UK Biobank project of the same size [43]. Alternatively, dried
blood samples on ﬁlter paper have the advantages of easy
storage and transport, as well as being less intrusive (i.e., by
ﬁnger prick rather than by venipuncture). Dried blood spots
have been recommended by the World Health Organization
for use in ﬁeld HIV-1 investigations and have been used in
various studies within India [48,49].
We currently plan pilot studies of dried blood spots or
tubes of blood among 4,000–9,000 adults in several SRS units
in four to ﬁve states. These pilots will focus on standardizing
methods to obtain anthropometric, behavioral, and physio-
logic measurements and to evaluate the alternative methods
for collection of biological specimens for their utility, cost,
and practicability (dried blood spot or tube of blood). The
pilots will focus on feasibility of ﬁeld methods, simpliﬁcation
of approaches, and quality control. The results of the pilot
studies, which are expected by June 2006, will help inform the
design of the larger survey. A special survey will help deﬁne
practicable questions on HIV-1 risk behaviors.
Long-Term Storage, Retrieval, and Analyses
We are undertaking systematic reviews of the literature
and reviewing available assays in India to examine which
current bioanalytic methods can be used to test current
hypotheses (either for correlates of infection or chronic
disease). Using the above pilot samples, we will develop
testing and analytic methods for biological samples that will
permit high-throughput, low-cost, and high-quality assays to
be run and also permit the long-term reliable storage and
retrieval of such samples. Dried blood spots may well be
stable in a basic 4 8C refrigerator, with minimal storage
requirements [46]. With a population of one billion, India
certainly requires at least two major biorepositories (includ-
ing splitting samples, which safeguards against loss at one
facility). We are developing plans for long-term bioreposito-
ries with the ability to store samples for decades. Much will
depend on the choice of the ﬁnal assay.
Nested Case-Control Methods and Genetic Association
Studies
There is a long list of biological factors in blood that might
be correlates of disease-speciﬁc mortality. To be efﬁcient, we
will use a nested case-control approach in our prospective
study. Biological samples are taken from all adults in a
baseline survey and stored long-term; then, when sufﬁcient
numbers of cases with the disease of interest have died (based
on the 6-mo follow-up of the causes of death), aliquots from
those cases are retrieved from storage, plus aliquots from a
few matched controls per case; and, ﬁnally, the factors of
interest are assayed in these cases and these controls. This
design is similar to that in the Chinese Kadoorie Study and
the UK Biobank project [43]. As noted above, the number of
deaths is likely to be substantial for most of the common
diseases of interest to make this an efﬁcient strategy.
Under some circumstances, studies that used population-
based controls to study gene-disease associations have been
biased due to underlying variation in gene frequencies
between populations (‘‘population stratiﬁcation’’ [50]). Ge-
netic epidemiology can provide reliable population-based
estimates of disease–allele frequency, penetrance, and attrib-
utable risk, particularly if designs that account for this bias are
employed, and accordingly this has led to greater emphasis
recently on family-based association designs. However, there
is also evidence that well-designed population-based studies
are sometimes superior [51]. The SRS offers a unique
opportunity to explore statistical design issues, as both
general population and family-based sampling is possible.
Family-based studies allow for population-speciﬁc estimates
of clustering of disease and correlation (heritability). Further,
families with a large number of siblings could be oversampled
to increase power for genetic linkage studies. The use of
‘‘genomic controls’’ where anonymous markers are genotyped
to test for population stratiﬁcation can be employed [52].
Limitations
The study has several limitations. First, despite a very large
sample size, the statistical power remains modest for less
common causes such as those leading to maternal deaths.
However, for most of the major public health conditions of
importance, sufﬁcient events should occur to generate
plausible absolute rates and relative risks for risk factors.
Second, careful attention in design means that most
identiﬁed biases should be minimized and should ensure
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Million Death Study in Indiahigh internal consistency of ﬁeldwork and coding. However,
periodic revalidation of mortality outcomes against external
standards will be needed. Similarly, continuous improvement
of exposure measurements, partially through careful pilots,
will be needed. Third, VA yields broad classiﬁcation of the
underlying causes in about 90% of deaths before age 70. In
old age, however, the proportion of classiﬁable deaths is
lower. For some speciﬁc conditions, such as childhood
pneumonia, the cause-speciﬁc fractions may be difﬁcult to
estimate below certain levels [53].
Significance to Global Health
The Million Death Study will reliably document not only
the underlying cause of child and adult deaths, but also key
risk factors (behavioral, physical, environmental, and even-
tually, genetic). It offers a globally replicable model for
reliably estimating cause-speciﬁc mortality, using VA, and
strengthens India’s ﬂagship mortality monitoring system.
Despite the misclassiﬁcation that is still expected, the new
cause-of-death data will be substantially better than that
available previously in India. The study builds India’s capacity
for research and for public health action. It provides a large,
representative, low-cost and long-term system to reliably
track the health status of one billion people for the next
decade or longer.
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Patient Summary
Background. A few pieces of information are crucial to measure the
health status of a population, which permits a sound basis for health
policy. One basic question is which diseases people die from. To answer
it, one needs to know the numbers and causes of death. The age at
which people die is critical to estimate the burden for society and to
develop strategies to prevent some of the deaths. In developed
countries, doctors determine and certify the causes of most deaths that
occur in hospitals. However, the majority of deaths worldwide in
developing countries occur at home and without reliable recording of
their causes and distribution. The present study takes place in India.
About one in six deaths worldwide occurs in India, or about 9.5 million
deaths per year. Only about a third of these deaths are registered.
Why Is This Study Being Done? The Indian government recognized the
need for better data on the distribution and causes of deaths across the
country and, together with an international group of researchers, is
undertaking a large study over 16 years (from 1998 to 2014) to collect
representative data for the country.
What Are the Researchers Doing? In this article, the researchers who
came up with the plan for the survey and will oversee its implementation
describe and discuss the details of the project. They will monitor,
through regular visits and interviews by surveyors, the health status of
nearly 14 million people in 2.4 million representative households from all
over India. The surveyors, who will be trained for the job but not have a
medical background, will collect information about the health status of
all household members and about key risk factors for disease such as
smoking, alcohol use, childhood immunization, and indoor air pollution.
About one million deaths are expected to occur among these people in
the study period. As part of their interviews, the surveyors will conduct
‘‘verbal autopsies,’’ that is, ask specific questions about how someone
died, to determine the causes of death. Each verbal autopsy will be
checked by two independent physicians (and a third if there is
disagreement) before the cause of death is recorded. The researchers
also describe their plans to extend the survey—they plan to collect
simple physical measurements such as blood pressure, height and
weight, and blood samples (most likely through a simple spot of blood
taken from the finger) from the participants. These biological samples
contain information about the genetic makeup of the individuals and,
potentially, on other markers that might be connected to the cause of
death, such as exposure to environmental toxins, the presence of viral or
bacterial infections, and others. This information will help them to
understand what caused the diseases that the people died from.
What Does This Mean? This study will provide the most accurate picture
of causes of childhood and adult death in India, as well as document key
risk factors. By studying diseases that are common in one part of India
but not in another, new risk factors will be identified and can be used to
reduce deaths overall. It will also serve as an example for other countries.
Where Can I Find More Information Online? The following Web sites
provide relevant information on this and similar large studies.
Full protocol, field instruments, training manuals, and more details for
this study:
http://www.cghr.org/project.htm
Home page of the UK Biobank:
http://www.ukbiobank.ac.uk/
Kadoorie study of chronic disease in China:
http://www.ctsu.ox.ac.uk/;kadoorie/public/
The World Health Organization’s Health Metrics Network:
http://www.who.int/healthmetrics/en/
Indepth Network for Continuous Demographic Evaluation of Populations
and Their Health in Developing Countries:
http://www.indepth-network.net
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